Compare NRIX & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | PLAB |
|---|---|---|
| Founded | 2009 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2020 | 1995 |
| Metric | NRIX | PLAB |
|---|---|---|
| Price | $17.75 | $32.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | $30.50 | ★ $44.33 |
| AVG Volume (30 Days) | 874.4K | ★ 1.1M |
| Earning Date | 04-08-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 0.74 |
| Revenue | $76,987,000.00 | ★ $535,276,000.00 |
| Revenue This Year | N/A | $6.70 |
| Revenue Next Year | $48.05 | $4.96 |
| P/E Ratio | ★ N/A | $46.79 |
| Revenue Growth | ★ 99.31 | 18.77 |
| 52 Week Low | $8.20 | $16.61 |
| 52 Week High | $22.50 | $56.00 |
| Indicator | NRIX | PLAB |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 28.98 |
| Support Level | $17.21 | $21.30 |
| Resistance Level | $19.98 | $38.00 |
| Average True Range (ATR) | 0.80 | 2.76 |
| MACD | 0.17 | -2.00 |
| Stochastic Oscillator | 88.45 | 2.93 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.